Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application

J **e, Y Bi, H Zhang, S Dong, L Teng, RJ Lee… - Frontiers in …, 2020 - frontiersin.org
Cell-penetrating peptides (CPPs) are short peptides (fewer than 30 amino acids) that have
been predominantly used in basic and preclinical research during the last 30 years. Since …

Cell penetrating peptides, novel vectors for gene therapy

RE Taylor, M Zahid - Pharmaceutics, 2020 - mdpi.com
Cell penetrating peptides (CPPs), also known as protein transduction domains (PTDs), first
identified~ 25 years ago, are small, 6–30 amino acid long, synthetic, or naturally occurring …

Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA/siRNA nanotherapy

Y **e, Y Hang, Y Wang, R Sleightholm, DR Prajapati… - ACS …, 2020 - ACS Publications
Nanomedicines achieve tumor-targeted delivery mainly through enhanced permeability and
retention (EPR) effect following intravenous (IV) administration. Unfortunately, the EPR effect …

The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery

MJ Saadh, H Baher, Y Li, JL Arias-Gonzáles… - Environmental …, 2023 - Elsevier
The multidisciplinary approaches in treatment of cancer appear to be essential in term of
bringing benefits of several disciplines and their coordination in tumor elimination. Because …

Truly tiny acoustic biomolecules for ultrasound imaging and therapy

B Ling, B Gungoren, Y Yao, P Dutka… - Advanced …, 2024 - Wiley Online Library
Nanotechnology offers significant advantages for medical imaging and therapy, including
enhanced contrast and precision targeting. However, integrating these benefits into …

Tumor-penetrating therapy for β5 integrin-rich pancreas cancer

T Hurtado de Mendoza, ES Mose, GP Botta… - Nature …, 2021 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is characterized by marked desmoplasia and
drug resistance due, in part, to poor drug delivery to extravascular tumor tissue. Here, we …

Targeting and monitoring ovarian cancer invasion with an RNAi and peptide delivery system

L Hao, N Boehnke, SK Elledge… - Proceedings of the …, 2024 - National Acad Sciences
RNA interference (RNAi) therapeutics are an emerging class of medicines that selectively
target mRNA transcripts to silence protein production and combat disease. Despite the …

Co-inhibition of the TGF-β pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti …

Y Wang, Z Gao, X Du, S Chen, W Zhang, J Wang… - Biomaterials …, 2020 - pubs.rsc.org
Pancreatic ductal adenocarcinoma (PDAC) has a dense extracellular matrix (ECM)
surrounding tumor cells to sequester CD8+ T cell infiltration and prevent drug penetration …

Peptide-based nanoparticles for therapeutic nucleic acid delivery

P Boisguérin, K Konate, E Josse, E Vivès, S Deshayes - Biomedicines, 2021 - mdpi.com
Gene therapy offers the possibility to skip, repair, or silence faulty genes or to stimulate the
immune system to fight against disease by delivering therapeutic nucleic acids (NAs) to a …

Regulation of tumor microenvironment for pancreatic cancer therapy

X Huang, L Ding, X Liu, R Tong, J Ding, Z Qian, L Cai… - Biomaterials, 2021 - Elsevier
Pancreatic cancer (PC) is one kind of the most lethal malignancies worldwide, owing to its
insidious symptoms, early metastases, and negative responses to current therapies. With an …